Antengene announces xpovio® (selinexor) approved for commercialization in thailand

Xpovio® is the first and only approved xpo1 inhibitor in thailand. xpovio® has been approved for multiple indications in nine markets across the apac region.
KPTI Ratings Summary
KPTI Quant Ranking